China SXT Pharmaceuticals Sets 1-for-100 Share Consolidation; SXTC Falls 31.5%

China SXT Pharmaceuticals, Inc. (SXTC) will implement a 1-for-100 consolidation of its Class A ordinary shares, effective October 26, 2026, with post-consolidation trading on Nasdaq expected to begin the same date under the existing ticker. The company had approximately 68.7 million ordinary shares outstanding, primarily Class A shares. Following the transaction, roughly 686,775 Class A shares and two Class B shares are expected to remain outstanding. Fractional shares will be rounded up to the next whole share. The consolidation applies only to Class A ordinary shares; Class B shares are unaffected. Outstanding stock options, warrants and other rights to purchase Class A shares will be adjusted proportionately. SXTC is currently trading at $0.05, down 31.51%.